Tag: Mental Health

The US pharmaceutical giant has put $906 million behind a next-generation psychedelic for depression, giving one of the industry’s largest ...

Emyria has begun treating its first patients at a new Sydney clinic, extending its Empax mental health services into New ...

For much of the past decade, the modern psychedelic renaissance has been accompanied by an unusually powerful media narrative. Drugs ...

Definium Therapeutics has reported a second positive Phase 3 trial of its LSD-based treatment for generalized anxiety disorder, strengthening the ...

Emyria (ASX: EMD) is preparing to open its first Sydney clinic in September, with the company saying key operational milestones ...

With six weeks to go until SCALE 2026, the international mental health and psychedelic medicine community is preparing to gather ...

Psychedelic medicine has spent the past decade developing clinical evidence almost exclusively in adults. Adolescents have largely remained outside the ...

For decades, psychedelic medicine sat on the margins of psychiatry, constrained by international drug controls, political controversy and the legacy ...

The psychedelic industry has no shortage of drug developers, clinical trials or investment pitches. What it has less of is ...

Emyria (ASX: EMD) has cleared a key operational bottleneck across its Perth and Queensland psychedelic-assisted therapy operations, with therapist availability ...